MDS trials: what should patients be looking for?

Rena Buckstein

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses the upcoming myelodysplastic syndromes (MDS) clinical trials. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Subject:

Myelodysplastic Syndromes

Medicines:

Luspatercept, Venetoclax

Event:

MDS 2020

Format:

Interview

Recorded:

5th March 2020